Legacy Reserves Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | $0.160 |
| EPS actual | $0.220 |
| EPS Surprise | 37.50% |
| Revenue estimate | 20.507M |
| Revenue actual | 21.369M |
| Revenue Surprise | 4.20% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.130 |
| EPS actual | $0.150 |
| EPS Surprise | 15.38% |
| Revenue estimate | 17.561M |
| Revenue actual | 19.185M |
| Revenue Surprise | 9.24% |
| Release date | Nov 13, 2025 |
| EPS estimate | $0.150 |
| EPS actual | $0.160 |
| EPS Surprise | 6.67% |
| Revenue estimate | 17.727M |
| Revenue actual | 19.401M |
| Revenue Surprise | 9.44% |
| Release date | Sep 25, 2025 |
| EPS estimate | $0.130 |
| EPS actual | $0.0900 |
| EPS Surprise | -30.77% |
| Revenue estimate | 16.79M |
| Revenue actual | 17.95M |
| Revenue Surprise | 6.91% |
Last 4 Quarters for Legacy Reserves
Below you can see how LGCY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 25, 2025 |
| Price on release | $12.32 |
| EPS estimate | $0.130 |
| EPS actual | $0.0900 |
| EPS surprise | -30.77% |
| Date | Price |
|---|---|
| Sep 19, 2025 | $12.86 |
| Sep 22, 2025 | $12.88 |
| Sep 23, 2025 | $12.45 |
| Sep 24, 2025 | $12.67 |
| Sep 25, 2025 | $12.32 |
| Sep 26, 2025 | $9.99 |
| Sep 29, 2025 | $9.95 |
| Sep 30, 2025 | $9.57 |
| Oct 01, 2025 | $9.66 |
| 4 days before | -4.20% |
| 4 days after | -21.59% |
| On release day | -18.91% |
| Change in period | -24.88% |
| Release date | Nov 13, 2025 |
| Price on release | $8.43 |
| EPS estimate | $0.150 |
| EPS actual | $0.160 |
| EPS surprise | 6.67% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $8.31 |
| Nov 10, 2025 | $8.57 |
| Nov 11, 2025 | $8.77 |
| Nov 12, 2025 | $8.97 |
| Nov 13, 2025 | $8.43 |
| Nov 14, 2025 | $9.46 |
| Nov 17, 2025 | $8.50 |
| Nov 18, 2025 | $8.66 |
| Nov 19, 2025 | $9.58 |
| 4 days before | 1.44% |
| 4 days after | 13.64% |
| On release day | 12.22% |
| Change in period | 15.28% |
| Release date | Feb 12, 2026 |
| Price on release | $10.04 |
| EPS estimate | $0.130 |
| EPS actual | $0.150 |
| EPS surprise | 15.38% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $10.34 |
| Feb 09, 2026 | $10.49 |
| Feb 10, 2026 | $10.65 |
| Feb 11, 2026 | $10.50 |
| Feb 12, 2026 | $10.04 |
| Feb 13, 2026 | $11.42 |
| Feb 17, 2026 | $12.17 |
| Feb 18, 2026 | $12.25 |
| Feb 19, 2026 | $12.23 |
| 4 days before | -2.90% |
| 4 days after | 21.81% |
| On release day | 13.75% |
| Change in period | 18.28% |
| Release date | May 14, 2026 |
| Price on release | $12.50 |
| EPS estimate | $0.160 |
| EPS actual | $0.220 |
| EPS surprise | 37.50% |
| Date | Price |
|---|---|
| May 08, 2026 | $11.70 |
| May 11, 2026 | $11.56 |
| May 12, 2026 | $11.92 |
| May 13, 2026 | $12.20 |
| May 14, 2026 | $12.50 |
| May 15, 2026 | $11.92 |
| May 18, 2026 | $12.00 |
| May 19, 2026 | $11.71 |
| May 20, 2026 | $11.76 |
| 4 days before | 6.84% |
| 4 days after | -5.92% |
| On release day | -4.64% |
| Change in period | 0.513% |
Legacy Reserves Earnings Call Transcript Summary of Q1 2026
Legacy Education reported a strong start to fiscal 2026 with continued enrollment-driven growth across key metrics. Q1 revenue rose 38.5% to $19.4 million, new student starts increased 31.6% to 1,117, and ending student population reached an all-time high of 3,495. Adjusted EBITDA increased 9.6% to $3.0 million (15.9% margin), while net income rose 4.6% to $2.2 million; diluted EPS was $0.16 (would be $0.22 on a normalized share count). Management emphasized front-loaded, strategic investments (new program development, simulation labs, faculty hiring, and increased marketing), which compressed margins year-over-year but are expected to drive sequential margin expansion as scale is realized. Four new program approvals (including MRI, cardiac sonography, surgical technology and sterile processing) began in Q2 with modest per-class capacities; management expects these to contribute in Q2/Q3 and reiterated a focus on organic growth, digital marketing, employer partnerships, hybrid delivery, and targeted M&A (multi-campus deals within and outside California). Balance sheet highlights: $20.6M cash, $17.6M AR (AR reserve $1.9M, 9.5% of AR), $72.1M total assets, low debt ($0.7M). Management noted that operating cash flow timing was affected by Title IV disbursement timing (not regulatory disruption) and that collections/delinquency trends are stabilizing following a disciplined reserve/write-off process and a collections partnership.
Sign In
Buy LGCY